glp-1 medications and anesthesia glp 1 Perioperative management of patients on receptor agonists: Risks, recommendations, and future directions—A narrative review Updated guidance for patients using

Understanding the distinction between central (brain-mediated) and peripheral effects of incretin-based therapies is essential for comprehending how tirzepatide exerts its therapeutic benefits

But the amount of weight lost can be different for everyone

This divergence may have implications for diabetes-associated ED, where NO bioavailability is essential

If semaglutide or tirzepatide did not produce adequate results, retatrutide different mechanism may be worth exploring

GLP-1s reliably deliver weight loss - the open question is whether that pharmacologic "quiet" can be leveraged for durable behavior change during the window when change is easiest

Theyre the most impactful drugs in the history of medicine, Dr